会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
    • 镇静剂和神经递质调节剂的组合,以及改善睡眠质量和治疗抑郁症的方法
    • US08097625B2
    • 2012-01-17
    • US11761235
    • 2007-06-11
    • Karim LaljiTimothy J. BarberichJudy CaronThomas Wessel
    • Karim LaljiTimothy J. BarberichJudy CaronThomas Wessel
    • A01N43/58A01N43/40A61K31/50A61K31/497A61K31/435
    • A61K31/4985A61K31/137A61K31/138A61K31/495A61K31/724A61K45/06A61K2300/00
    • One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., insomnia and/or depression. The first component of the pharmaceutical composition is a GABA receptor modulating compound. The second component of the pharmaceutical composition is a serotonin reuptake inhibitor, a norepinephrine reuptake inhibitor, a 5-HT2A modulator, or dopamine reuptake inhibitor. In certain embodiments, the pharmaceutical composition comprises eszopiclone. In a preferred embodiment, the pharmaceutical composition comprises eszopiclone and fluoxetine. The present invention also relates to a method of treating a sleep abnormality, treating insomnia, treating depression, augmenting antidepressant therapy, eliciting a dose-sparing effect, reducing depression relapse, improving the efficacy of antidepressant therapy or improving the tolerability of antidepressant therapy, comprising co-administering to a patient in need thereof a GABA-receptor-modulating compound; and a SRI, NRI, 5-HT2A modulator or DRI.
    • 本发明的一个方面涉及含有两种或更多种活性剂的药物组合物,当它们一起被用于治疗,例如失眠和/或抑郁症时。 药物组合物的第一组分是调节GABA受体的化合物。 药物组合物的第二组分是5-羟色胺再摄取抑制剂,去甲肾上腺素再摄取抑制剂,5-HT2A调节剂或多巴胺再摄取抑制剂。 在某些实施方案中,药物组合物包含依佐匹克。 在优选的实施方案中,药物组合物包含依佐匹克和氟西汀。 本发明还涉及一种治疗睡眠异常,治疗失眠,治疗抑郁症,增强抗抑郁药治疗,引发剂量保留作用,减少抑郁症复发,改善抗抑郁治疗疗效或提高抗抑郁治疗耐受性的方法,包括 向有需要的患者共同施用GABA受体调节化合物; 和SRI,NRI,5-HT2A调节剂或DRI。